Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
Sight Diagnostics, an Israeli medical devices startup that’s using AI technology to speed up blood testing, has closed a $27.8 million Series C funding round.
The company has built a desktop machine, called OLO, that analyzes cartridges manually loaded with drops of the patient’s blood — performing blood counts in situ.
The new funding is led by VC firm Longliv Ventures, also based in Israel, and a member of the multinational conglomerate CK Hutchison Group.
Sight Diagnos
Read more »